Weekly update from PND
Candid
OCTOBER 22, 2021
To be allocated in consultation with partner organizations, the funding will support efforts to develop and manufacture generic versions of the drug, which is being developed by Merck & Co. in collaboration with Ridgeback Biotherapeutics. Read more. . Global Citizen Year receives $12 million grant from MacKenzie Scott. October 20, 2021.
Let's personalize your content